MindWalk Holdings HYFT
NASDAQ HYFT
$1.32 -0.01 (-0.75%)
At close: Sep 4, 2026 · 4:00 PM EDT

MindWalk Holdings (HYFT) Amortization - Intangibles (2020 - 2025)

MindWalk Holdings (HYFT) posted quarterly Amortization - Intangibles of $374.7 for Q1 2026, down 99.9% year-over-year from $366302.0 in Q1 2025, and up 2.52% quarter-over-quarter from $365.49 in Q4 2025.

Analysis

MindWalk Holdings (HYFT) Amortization - Intangibles (2020 - 2025) Analysis & Trends

MindWalk Holdings (HYFT) has reported Amortization - Intangibles for 6 consecutive years, with $374.7 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Amortization - Intangibles fell 99.9% year-over-year to $374.7; the TTM figure through Apr 2026 stood at $740.18 (down 100.0% YoY), while the FY2025 annual figure was $1.1 million, down 37.35% from the prior year.
  • Amortization - Intangibles improved to $374.7 in Q1 2026 per HYFT's latest filing, from $365.49 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $634.6 million in Q3 2023 and bottomed at $365.49 in Q4 2025.
  • Historically, Amortization - Intangibles has averaged $117.7 million across 5 years, with a median of $524462.5 in 2024.
  • Annual changes were most pronounced in 2023 — Amortization - Intangibles surged 62587.26% — and 2024, when it plunged 99.93%.
  • MindWalk Holdings' Amortization - Intangibles stood at $836466.8 in 2022, then soared by 62587.26% to $524.4 million in 2023, then slumped by 99.93% to $371270.4 in 2024, then tumbled by 99.9% to $365.49 in 2025, then rose by 2.52% to $374.7 in 2026.
  • Business Quant data shows HYFT's Amortization - Intangibles at $374.7 in Q1 2026, $365.49 in Q4 2025, and $492.61 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 MindWalk Holdings 61.22 Mn 52.95 Mn 1.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2025 492,612.81
Jan 31, 2025 366,301.96
Oct 31, 2024 371,270.37
Jul 31, 2024 366.62 Mn
Apr 30, 2024 73,014.51
Jan 31, 2024 524,462.53
Oct 31, 2023 524.36 Mn
Jul 31, 2023 634.58 Mn
Apr 30, 2023 973,327.77
Jan 31, 2023 765,860.44
Oct 31, 2022 836,466.82
Apr 30, 2021 707,840.63
Jan 31, 2021 727,699.13
Oct 31, 2020 736,465.90
Apr 30, 2020 968,364.38
Jan 31, 2020 595,134.15